Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial

Radiotherapy and Oncology

Volumn 75, Issue 2, 2005, Pages 193-196

  Merlano, Marco ^a   Russi, Elvio G ^a   Numico, Gianmauro ^a   Colantonio, Ida ^a   Garrone, Ornella ^a   Pelissero, Antonio ^a   Granetto, Cristina ^a   Gasco, Milena ^a   Di Costanzo, Gianna ^a   Heouaine, Abdelhamid ^a   Taglianti, Riccardo Vigna ^a   Cipolat, Marco ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Chemoradiation; Head and neck cancer; Paclitaxel

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; ERYTHROPOIETIN; FLUOROURACIL; HEMOGLOBIN; MORPHINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTHRALGIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSPHAGIA; EDEMA; EPIGLOTTIS; ESOPHAGUS STRICTURE; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPENIA; MALE; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; PAIN; PEPTIC ULCER BLEEDING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION PNEUMONIA; SENSORY NEUROPATHY; SIDE EFFECT; SKIN TOXICITY; SOFT TISSUE DISEASE; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; TISSUE NECROSIS; TONSIL DISEASE; TREATMENT OUTCOME; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME;

EID: 20444430040     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.11.007     Document Type: Article

References (19)

1. D.J. Adelstein, J.P. Saxton, and P. Lavertu Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy J Clin Oncol 20 2002 1405 1410
2. K.K. Ang, J.H.A.M. Kaander, and L.J. Peters Radiotherapy for head and neck cancers 1994 Lea and Febiger Philadelphia, PA
3. M. Benasso, R. Corvò, and A. Ponzanelli Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck Ann Oncol 15 2004 646 652
4. M. Benasso, G. Numico, and R. Rosso Chemotherapy for relapsed head and neck cancer: paclitaxel, cisplatin and 5-fluorouracil in chemotherapy naive patients. A dose-finding study Semin Oncol 24 1997 46 50
5. M. Benasso, A. Ponzanelli, and I. Ricci Multicenter phase II study. of paclitaxel, cisplatin (CDDP) and 5-fluorouracil (5-FU) in chemotherapy-naive patients with relapsed squamous cell carcinoma of the head and neck (SCC-HN) Proc ASCO 2003 516 [abstract n. 2075]
6. J. Bourhis, C. Amand, and J.-P. Pignon Update of MACH-NC (Meta-Analysis of Chemotherapy in Head and Neck Cancer) database focused on concomitant chemoradiotherapy. Proc ASCO 2004 J Clin Oncol 22 2004 [abstract n. 5505]
7. B. Brockstein, D.J. Haraf, and K. Stenson Phase I trial study of concomitant chemoradiotherapy with paclitaxel, fluorouracil and hydroxiurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck J Clin Oncol 16 1998 735 744
8. R. Corvò, M. Benasso, and G. Sanguineti Alternating chemoradiotherapy vs partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck Cancer 92 2001 2856 2867
9. G.B. Haffty Concurrent chemoradiation in the treatment of head and neck cancer Hematol Oncol Clin North Am 13 1999 719 742
10. P. Hermanek, R.V.P. Hutter, L.H. Sobin, G. Wagner, and Ch. Wittekind TNM Atlas 1997 Springer Berlin
11. R. Hitt, A. Lopez-Posua, and M. Rodriguez Phase III study comparing cisplatin (P) and 5-fluorouracil (F) versus P, F and paclitaxel (T) as induction therapy in locally advanced head and neck cancer Proc ASCO 22 2003 496 [Abstract n. 1997]
12. W. Hoffmann, C. Belka, and H. Schmidberger Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer. Results from phase I trial Int J Radiat Oncol Biol Phys 38 1997 691 696
13. M.S. Kies, D.J. Haraf, and F. Rosen Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer Clin Oncol 19 2001 1961 1969
14. M. Merlano, M. Benasso, and R. Corvò Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 1996 583 589
15. M. Merlano, V. Vitale, and R. Rosso Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy N Engl J Med 327 1992 1115 1121
16. A.B. Miller, B. Hoogstraten, and M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
17. J.P. Pignon, J. Bourhis, C. Domenge, and L. Designè Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 9208 2000 949 955
18. D.M. Shin, B.S. Glisson, and F.R. Khuri Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck Semin Oncol 24 1997 33 37
19. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10